摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-[2-[[2-(Aminomethyl)-3-[3-(1,3-dihydroxypropan-2-yloxy)-2-(1,3-dihydroxypropan-2-yloxymethyl)propoxy]propoxy]methyl]-3-(1,3-dihydroxypropan-2-yloxy)propoxy]propane-1,3-diol | 873200-59-0

中文名称
——
中文别名
——
英文名称
2-[2-[[2-(Aminomethyl)-3-[3-(1,3-dihydroxypropan-2-yloxy)-2-(1,3-dihydroxypropan-2-yloxymethyl)propoxy]propoxy]methyl]-3-(1,3-dihydroxypropan-2-yloxy)propoxy]propane-1,3-diol
英文别名
——
2-[2-[[2-(Aminomethyl)-3-[3-(1,3-dihydroxypropan-2-yloxy)-2-(1,3-dihydroxypropan-2-yloxymethyl)propoxy]propoxy]methyl]-3-(1,3-dihydroxypropan-2-yloxy)propoxy]propane-1,3-diol化学式
CAS
873200-59-0
化学式
C24H51NO14
mdl
——
分子量
577.667
InChiKey
ANNNQXPFRLSDEH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -6
  • 重原子数:
    39
  • 可旋转键数:
    29
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    243
  • 氢给体数:
    9
  • 氢受体数:
    15

反应信息

点击查看最新优质反应信息

文献信息

  • Efficient relaxivity enhancement in dendritic gadolinium complexes: effective motional coupling in medium molecular weight conjugates
    作者:David A. Fulton、Mark O'Halloran、David Parker、Kanthi Senanayake、Mauro Botta、Silvio Aime
    DOI:10.1039/b413536a
    日期:——
    Enhancement of the relaxivities of Gd-based MRI contrast agents is achieved by placing the metal ion at the barycentre of the molecular complex in order to improve motional coupling.
    通过将属离子置于分子复合物的双中心以改善运动耦合,可以增强基磁共振成像造影剂的弛豫性。
  • Contrast Agents Endowed with High Relaxivity for Use in Magnetic Resonance Imaging (Mri) Which Contain a Chelating Moiety with Polyhydroxylated Substituents
    申请人:Aime Silvio
    公开号:US20070258905A1
    公开(公告)日:2007-11-08
    The present invention relates to a new class of paramagnetic ion-based contrast agents of molecular weight lower than 3.5 kDa that show a pharmacokinetic profile analogous to that of the commonly used T1-general extravascular agents and that are further characterized by a higher relaxivity.
    本发明涉及一种新的顺磁离子基对比剂,其分子量低于3.5 kDa,显示类似于常用的T1通用非血管内对比剂的药代动力学特征,并且具有更高的弛豫度。
  • Contrast agents endowed with high relaxivity
    申请人:Aime Silvio
    公开号:US20110256067A1
    公开(公告)日:2011-10-20
    The present invention relates to a novel class of paramagnetic ion-based contrast agents of formula (I), wherein a chelating backbone moiety is highly functionalized by the presence of one or more polyhydroxylated chain, that show a pharmacokinetic profile analogous to that of the commonly used T1-general extravascular agents (NSA) but are further characterized by a higher relaxivity.
    本发明涉及一种新型的基于顺磁离子的对比剂类别,其化学式为(I),其中螯合骨架部分通过一个或多个多羟基链的存在高度功能化,表现出与常用的T1通用非血管外用对比剂(NSA)相似的药代动力学特征,但具有更高的弛豫度。
  • CONTRAST AGENTS ENDOWED WITH HIGH RELAXIVITY FOR USE IN MAGNETIC RESONANCE IMAGING (MRI) WHICH CONTAIN A CHELATING MOIETY WITH POLYHYDROXYLATED SUBSTITUENTS
    申请人:Bracco Imaging S.p.A
    公开号:EP1765812B1
    公开(公告)日:2009-04-29
  • 1,4-BIS(CARBOXYMETHYL)-6-[BIS(CARBOXYMETHYL)AMINO]-6-METHYL-PERHYDRO-1,4-DIAZEPINE (AAZTA) DERIVATIVES AS LIGANDS IN HIGH RELAXIVITY CONTRAST AGENTS FOR USE IN MAGNETIC RESONANCE IMAGING (MRI)
    申请人:Bracco Imaging S.p.A
    公开号:EP1786475B1
    公开(公告)日:2009-04-29
查看更多